Key facts
- This page summarizes Michael Eric Smith's Form 4 filing for Danimer Scientific, Inc. (DNMRQ).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Aug 2021, 19:11.
Michael Eric Smith - 17 Aug 2021 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- DNMRQ
- Reported as of
- 17 Aug 2021
- Net transaction value
- -$114,470
- SEC form
- 4
- Accepted by SEC
- 19 Aug 2021, 19:11:56 UTC
- Next SEC filing
- 20 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Smith
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Eric Smith filed Form 4 for Danimer Scientific, Inc. (DNMRQ) on 19 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$114,470.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNMR
transaction
Class A Common Stock ("Common Stock")
Options Exercise
- Transaction value
- $32,800
- Shares
- +10,000
- Change %
- +2.7%
- Price
- $3.28
- Shares after
- 387,259
- Date
- 17 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
DNMR
transaction
Common Stock
Sale
- Transaction value
- $147,270
- Shares
- -10,000
- Change %
- -2.6%
- Price
- $14.73*
- Shares after
- 377,259
- Date
- 17 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DNMR
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -1.5%
- Price
- $0.000000
- Shares after
- 668,909
- Date
- 17 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $3.28
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Includes 377,259 restricted shares of the Common Stock granted under a previously disclosed restricted stock award.
Footnote F2
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Smith on June 25, 2021. The Reporting Person exercised no discretion with respect to the sale. Proceeds from the sale were used to pay the exercise price of stock options, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes.
Footnote F3
The August 17, 2021 sale of 10,000 shares of Common Stock was executed in multiple trades at prices ranging from $14.01 to $15.14. The price reported above reflects the volume-weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F4
The options are fully vested and currently exercisable.
Footnote F5
Reflects the aggregate amount of options owned by Reporting Person having the exercise price, grant date and expiration date reported above, but which options were previously reported on two separate entries in a prior filing.